Synthetic heptapeptide

Selank

Thr-Lys-Pro-Arg-Pro-Gly-Pro

Not FDA-approved in the U.S.

A synthetic peptide studied in neurobehavioral and stress-response research, with limited high-quality clinical evidence available in U.S. regulatory sources.

FULL RESEARCH GRAPHIC

Selank research overview

A dedicated overview of Selank, stress-response and neurotransmission research, and the 10 mg vial.

Cybertide Selank 10 mg research infographic covering stress-response and cognition research

Tap the graphic to open the full-resolution version.

CYBERTIDE // VISUAL PROFILESelank
PROFILE09
IDENTITYThr-Lys-Pro-Arg-Pro-Gly-ProSynthetic heptapeptide

RESEARCH SIGNAL MAP

04 ACTIVE FIELDS
NODE 01Stress-response biology
NODE 02Neurobehavioral models
NODE 03Functional connectivity
NODE 04Immune signaling

EVIDENCE READOUT

Not FDA-approved in the U.S.

Research findings are not the same as proof of an anxiolytic or nootropic treatment, particularly when product quality and route vary.

BOUNDARY CHECK

CONTEXT REQUIRED

FDA says it lacks important information needed to understand the safety of compounded Selank acetate administered to humans.

RESEARCH CONTEXT • PRIMARY SOURCE LINKED • QR READYSOURCE ↗

SUBMITTED LAB DOCUMENTS

Test results

Reports may describe other strengths or blends. Match the labeled amount, composition, and exact lot to your vial. A report for another strength does not verify your vial. Each record identifies whether an exact lot was supplied.

VIAL REFERENCE

3 mL mixing math & dosing context

Every number is labeled by evidence level. The 3 mL reference calculates concentration and U-100 volume; it does not prove solvent compatibility, sterility, stability, or suitability for injection.

VIAL STRENGTH

10 mg vial

AFTER 3.0 mL3.33 mg/mL0.03 mg per U-100 unit
AMOUNTVOLUMEU-100
100 mcg0.03 mL3 units
250 mcg0.07 mL7.5 units
500 mcg0.15 mL15 units
LIVE CALCULATOR

Change the liquid. See the amount.

U-100
CONCENTRATION3.333 mg/mL
DRAW VOLUME0.1 mL
AMOUNT IN THAT DRAW0.333 mg333.3 mcg

Calculation only: vial amount ÷ liquid volume × draw volume. It does not determine what dose to use or confirm product compatibility.

01 / MIXING REFERENCE

3.0 mL BAC-water workflow

  1. First confirm that bacteriostatic water and a 3.0 mL final volume are compatible with the exact product and vial capacity.
  2. Clean both vial stoppers with alcohol and allow them to dry.
  3. Add the 3.0 mL slowly down the inside wall instead of directing pressure onto the powder.
  4. Gently roll or swirl until dissolved; do not shake.
  5. Use product-specific refrigeration and discard guidance. If none exists, do not invent a beyond-use date.
NO ESTABLISHED HUMAN GUIDELINE

No standardized U.S. human dose

Selank is not FDA-approved in the United States, and FDA says important information needed to understand the safety of compounded Selank acetate in humans is lacking.

FDA — compounding safety risks ↗

U-100 means 100 units = 1.0 mL. Any table result above 100 units exceeds one standard 1 mL U-100 syringe.

PRIMARY CONTEXTFDA — compounding safety risks
Open source ↗
NEXT INFOGRAPHICPT-141 →